| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/28/2004 | EP1411966A2 Method for treating secondary tissue degeneration associated with central nervous system injury |
| 04/28/2004 | EP1411965A1 Methods and compositions for controlling protein assembly or aggregation |
| 04/28/2004 | EP1411961A1 Use of ginkgo biloba extracts for preparing a medicine for treating sarcopenia |
| 04/28/2004 | EP1411960A1 Fortified rice bran food product and method for promoting cardiovascular health |
| 04/28/2004 | EP1411959A1 Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 |
| 04/28/2004 | EP1411956A1 Use of oversulfated polysaccharides as inhibitors of hiv |
| 04/28/2004 | EP1411954A2 Modified nucleosides for treatment of viral infections and abnormal cellular proliferation |
| 04/28/2004 | EP1411953A1 Methods and compositions for treatment of gastric diseases |
| 04/28/2004 | EP1411952A1 Use of at least one glycoinhibitor substance |
| 04/28/2004 | EP1411951A2 Enteral compositions for the prevention and/or treatment of sepsis |
| 04/28/2004 | EP1411950A2 Treatment of ocular hypertension and glaucoma |
| 04/28/2004 | EP1411949A2 8/17 heterocyclic compounds and uses thereof as d-alanyl-d-alanine ligase inhibitors |
| 04/28/2004 | EP1411948A1 Tetrahydroquinoxalines acting as bradykinin antagonists |
| 04/28/2004 | EP1411947A2 Salts of substituted 1, 2, 3, 4-tetrahydroisoquinoline-2-carboxylic acid derivatives |
| 04/28/2004 | EP1411946A1 Use of nk-1 receptor antagonists to modify unwanted behavior in dogs, cats and horses |
| 04/28/2004 | EP1411945A1 Substituted pyridin-4-ones and their use as gonadotropin-releasing hormone receptor antagonists |
| 04/28/2004 | EP1411944A1 Sulfonamide derivatives as gamma secretase inhibitors |
| 04/28/2004 | EP1411943A2 Methods for treatment of cognitive and menopausal disorders with d-threo methylphenidate |
| 04/28/2004 | EP1411942A1 Substituted anilinic piperidines as mch selective antagonists |
| 04/28/2004 | EP1411941A2 Pyridinone and pyridazinone derivatives as gonadotropin-releasing hormone receptor antagonists |
| 04/28/2004 | EP1411940A1 Bridged piperidine derivatives as melanocortin receptor agonists |
| 04/28/2004 | EP1411939A2 Gaba a-receptor-modulators having nmda-antagonistic activity |
| 04/28/2004 | EP1411938A1 Use of cyclopamine in the treatment of psoriasis |
| 04/28/2004 | EP1411936A1 Use of thiazole derivatives for the manufacture of a medicament for the treatment of chronic obstructive pulmonary disease |
| 04/28/2004 | EP1411935A1 Use of 4- (4-thiazolyl)phenoxl] alkoxy-benzamidine derivatives for treatment of osteoporosis |
| 04/28/2004 | EP1411934A1 Treatment of chronic pain with 3-heterocyclyl- and 3-cycloalkyl-3-aryloxypropanamines |
| 04/28/2004 | EP1411933A1 Alpha-ketoamide derivatives as cathepsin k inhibitors |
| 04/28/2004 | EP1411932A1 Substituted oxazolidinones for combinational therapy |
| 04/28/2004 | EP1411931A1 Zonisamide use in headache |
| 04/28/2004 | EP1411929A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 04/28/2004 | EP1411928A1 Viral polymerase inhibitors |
| 04/28/2004 | EP1411927A1 Method for the preparation of selectively-substituted corroles and new substituted corroles |
| 04/28/2004 | EP1411926A1 Integrin inhibitors for the treatment of eye diseases |
| 04/28/2004 | EP1411925A1 5-arylsulfonyl indoles having 5-ht6 receptor affinity |
| 04/28/2004 | EP1411924A1 Hypertension treatment |
| 04/28/2004 | EP1411923A1 Pharmaceutical compositions of amlodipine and atorvastatin |
| 04/28/2004 | EP1411922A1 Pharmaceutical compositions, kits and methods comprising combinations of estrogen agonists/antagonists, estrogens and progestins |
| 04/28/2004 | EP1411921A1 Pharmaceutical compositions containing terbinafin and use thereof |
| 04/28/2004 | EP1411920A2 Use of epigallocatechin-3-gallate or derivatives thereof in the prophylaxis and treatment of neurodegenerative diseases |
| 04/28/2004 | EP1411919A1 (-)-olivil as antioxidant |
| 04/28/2004 | EP1411918A2 Methods to mobilize progenitor/stem cells |
| 04/28/2004 | EP1411917A1 Carbamate compounds for use in preventing or treating movement disorders |
| 04/28/2004 | EP1411916A2 Methods and materials for the treatment of testosterone deficiency in men |
| 04/28/2004 | EP1411915A2 Nitrate ester-cyclodextrin complexes for treating diseases, particularly coronary diseases |
| 04/28/2004 | EP1411914A2 Use of a pde4 inhibitor in combination with an anticholinergic agent for the treatment of pulmonary disease such as asthma |
| 04/28/2004 | EP1411913A1 Antimicrobial nanoemulsion compositions and methods |
| 04/28/2004 | EP1411912A1 Treatment of chronic pain with 3-aryloxy-3-phenylpropanamines |
| 04/28/2004 | EP1411911A1 Beta-adrenergic blockade reversal of catabolism after severe burn |
| 04/28/2004 | EP1411910A1 (+)-cycloolivil as antioxidant obtained from stereospermum personatum |
| 04/28/2004 | EP1411909A1 Pharmaceutical composition comprising (-)-secoisolariciresinol |
| 04/28/2004 | EP1411908A1 Treatment of nail infections with no |
| 04/28/2004 | EP1411907A1 Inhibitors of hb-egf (erbb) receptors for treating myeloma |
| 04/28/2004 | EP1411905A1 Sustained release delivery system |
| 04/28/2004 | EP1411904A1 Sustained release pharmaceutical composition |
| 04/28/2004 | EP1411901A1 Gastric retention controlled drug delivery system |
| 04/28/2004 | EP1411900A2 PHARMACEUTICAL COMPOSITIONS FOR THE COORDINATED DELIVERY OF NSAIDs |
| 04/28/2004 | EP1411899A2 Taste masking composition |
| 04/28/2004 | EP1411897A2 Compositions and methods for intracellular delivery |
| 04/28/2004 | EP1411896A2 Surfactant compounds and uses thereof |
| 04/28/2004 | EP1411895A2 Oral pharmaceutical composition comprising an active principle capable of being subjected to high effect during its first passage through the intestine |
| 04/28/2004 | EP1411894A2 Pharmaceutical preparations containing ion exchange resins charged with active ingredients |
| 04/28/2004 | EP1411889A1 Cream for treatment of skin injured by the sun |
| 04/28/2004 | EP1411881A2 5HT sb 2C /sb RECEPTOR MODULATORS |
| 04/28/2004 | EP1411879A1 A composition and uses therefor for combating hangover |
| 04/28/2004 | EP1411780A1 Soluble roasted chicory with high inulin content |
| 04/28/2004 | EP1411765A1 Enhancement of the stability of oligonucleotides comprising phosphorothioate linkages by addition of water-soluble antioxidants |
| 04/28/2004 | EP1307539A4 Gene expression profile for kshv infection and methods for treating same |
| 04/28/2004 | EP1307213B1 Chlorella preparations exhibiting immunomodulating properties |
| 04/28/2004 | EP1294682B1 Acylphenyl urea derivatives, methods for the production thereof and use thereof as a medicament |
| 04/28/2004 | EP1289986B1 1,4-diazabicyclo 3.2.2]nonane-phenylisoxazole derivatives, preparation and therapeutic use thereof |
| 04/28/2004 | EP1263718B1 Novel use of phenylheteroalkylamine derivatives |
| 04/28/2004 | EP1263715B1 Novel phenylheteroalkylamine derivatives |
| 04/28/2004 | EP1263714B1 Novel phenylheteroalkylamine derivatives |
| 04/28/2004 | EP1255559B1 Use of inhibitors of caspase-3 or caspase-activated desoxyribonuclease (cad) for treating cardiac disease |
| 04/28/2004 | EP1244642B1 Substituted oxazoles and thiazoles derivatives as hppar alpha activators |
| 04/28/2004 | EP1230237B1 Magnesium omeprazole |
| 04/28/2004 | EP1208096B1 Substituted pyridazines and fused pyridazines with angiogenesis inhibiting activity |
| 04/28/2004 | EP1206448B1 Novel vitamin d analogues |
| 04/28/2004 | EP1162981B1 Dexrazoxane for the treatment of accidental extravasation of anthracyclines |
| 04/28/2004 | EP1154983B1 Novel substituted 3-phenoxy and 3-phenylalkyloxy-2-phenyl-propylamines |
| 04/28/2004 | EP1153024B1 2-amino-6-anilino-purines and their use as medicaments |
| 04/28/2004 | EP1140197B1 Soluble compositions of toremifene |
| 04/28/2004 | EP1137631B1 REVERSIBLE AQUEOUS pH SENSITIVE LIPIDIZING REAGENTS, COMPOSITIONS AND METHODS OF USE |
| 04/28/2004 | EP1135124B1 Antihypertriglyceridemic, antihyperglycemic, anti-angiogenic and wound healing substituded indolealkanoic acids |
| 04/28/2004 | EP1126829B1 Particles coated with granulated crystalline ibuprofen |
| 04/28/2004 | EP1107737B1 Microparticles for use in needleless injection |
| 04/28/2004 | EP1087970B1 PYRROLO 2,3-d]PYRIMIDINE COMPOUNDS |
| 04/28/2004 | EP1083171B1 Pyrazoline derivatives, their preparation and application as medicaments |
| 04/28/2004 | EP1051394B1 Potassium channel inhibitors |
| 04/28/2004 | EP1042313B1 Benzopyran and benzothiopyran derivatives having retinoid antagonist like activity |
| 04/28/2004 | EP1039892B1 Use of polyunsaturated fatty acids for reducing the incidence of necrotizing enterocolitis |
| 04/28/2004 | EP1009407B1 Noribogaine in the treatment of pain and drug addiction |
| 04/28/2004 | EP0971922B1 Tetrahydropyrido compounds |
| 04/28/2004 | EP0937045B1 N-aryl substituted tetrahydroquinolines ligands for retinoid receptors having agonist, antagonist or inverse agonist type activity |
| 04/28/2004 | EP0915842B1 Nitrate esters and their use for neurological conditions |
| 04/28/2004 | EP0913157B1 A composite vaccine which contains antigen, antibody and recombinant dna and its preparing method |
| 04/28/2004 | EP0912174B1 Alteration of circadian rhythmicity with non-peptidal neurikinin-1 receptor antagonists |
| 04/28/2004 | EP0910645B1 A KINASE CAPABLE OF SITE-SPECIFIC PHOSPHORYLATION OF I-kappa-B-alpha |
| 04/28/2004 | EP0888271B1 Benzamidine derivatives substituted by amino acid and hydroxy acid derivatives and their use as anti-coagulants |
| 04/28/2004 | EP0885309B1 Direct molecular diagnosis of friedreich ataxia |